Skip to product information
1 of 1

CDK9-IN-37

CDK9-IN-37

Size

SKU:QM-0011562

Price on request
Quantity

Request quote or documents

View full details
  • Description

    CDK9-IN-37 (Compound 24) is a CDK9 inhibitor (EC50: 5.5 nM) with weak inhibition on other CDK isoforms, showing high selectivity. CDK9-IN-37 has significant antiproliferative activity against acute myeloid leukemia MOLM-13 cells (IC50: 0.034 μM) . CDK9-IN-37 inhibits the CDK9 signaling pathway, reduces the phosphorylation level of RNAP II CTD (Ser2), downregulates the anti-apoptotic protein McI-1, induces cell apoptosis, and arrests the cell cycle at the G2/M phase. CDK9-IN-37 can be used in the study of acute myeloid leukemia (AML) [1].

  • Molecular Formula

    C20H19FN2O4S2

  • Molecular Weight

    434.5

  • Smiles

    CCOC1=C(C(C2=CN=C(NC3=CC(C)=CC(S(=O)(C)=O)=C3)S2)=O)C=CC(F)=C1

  • Target

    CDK

  • Isoform

    CDK9

  • Shipping Conditions

    Room temperature

Your cart
Variant Variant total Quantity Price Variant total
1 EachQM-0011562
1 EachQM-0011562
£0.00/ea
£0.00
£0.00/ea £0.00

CDK9-IN-37

CDK9-IN-37 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.